Park Medi World IPO subscribed 11.05 times overall on the last day. A retail quota was subscribed over 1.81 times, NII was subscribed over 17.05 times, and QIB was subscribed over 23.65 times.
Park Medi World IPO details
Park Medi World received SEBI approval for an IPO of ₹920 crores, comprising a fresh issue of ₹770 crores and an offer for sale of up to 92,59,259 equity shares with a face value of ₹2 each. The Company has a price band of ₹154 to ₹162 per share.
How many shares did investors receive in this IPO??
- Retail minimum investors got 92 shares in 1 lot size.
- Retail Maximum investors got 1,196 shares, 13 lot sizes.
- S-HNI minimum investors got 1,288 shares, 14 lot sizes.
- S-HNI Maximum investors got 6,164 shares, 67 shares.
- B-HNI minimum got 6,256 shares, 68 lot sizes.
To invest in the Park Medi World IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,904.
- Retail Investors: Maximum investment of ₹1,93,752.
- SHNI (S-HNI): Minimum investment of ₹2,08,656.
- S-HNI Max: investment of ₹9,98,568.
- B-HNI: Minimum investment of ₹10,13,472.
Park Medi World IPO Subscription Duration
Park Medi World IPO subscription started on December 10, 2025, and closed on December 12, 2025. The Park Medi World IPO allotment date was December 15, 2025, and the refund will be received on December 16, 2025. The Park Medi World IPO listing is on December 17, 2025.
Park Medi World IPO Funds Deployment
- The proceeds raised from the fresh issue will be used for Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries.
- A portion of the revenue will be utilized towards Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively.
- Funding capital expenditure to be incurred on account of purchase of machinery and equipment by the company.
- A portion of the funds will be used towards Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri.
- Funding inorganic growth through Unidentified inorganic acquisitions and general corporate purposes.
About the Park Medi World IPO Company
Park Medi World is the only precision components company in India to offer fully integrated manufacturing for the aerospace sector. What sets them apart is that they provide a fully integrated making for aerospace, which gives them an advantage over other contract manufacturers who only offer a few services.
Park Medi World has the largest aerospace product portfolio in India, including components for engine systems, landing systems, cargo and interiors, structures, assemblies, and turning parts for aerospace clients. Furthermore, the company has produced over 4,500 aerospace products as of March 31, 2025.
